Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism
Inhibition of glucose-induced insulin secretion by interleukin-1β (IL-1β), or IL-1β plus tumour necrosis factor-α (TNF-α), was less marked when rat islets of Langerhans were cultured for 12 h with these cytokines in L-arginine-free medium as opposed to medium containing L-arginine (1 mM). Inhibition...
Saved in:
Published in | FEBS letters Vol. 276; no. 1; pp. 42 - 44 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
10.12.1990
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Inhibition of glucose-induced insulin secretion by interleukin-1β (IL-1β), or IL-1β plus tumour necrosis factor-α (TNF-α), was less marked when rat islets of Langerhans were cultured for 12 h with these cytokines in L-arginine-free medium as opposed to medium containing L-arginine (1 mM). Inhibition of secretion by IL-1β was further alleviated when islets were maintained in L-arginine-free medium supplemented with
N-ω-nitro-L-arginine methyl ester (NAME), while synergism between IL-1β plus TNF-α was completely abolished. Tissue culture medium nitrite levels were raised in islets treated with IL-1β or TNF-α (48 h). Cytokine-stimulated nitrite production was not observed in islets cultured with NAME (1 mM). In conclusion, an L-arginine-dependent nitric oxide generating mechanism is involved in the inhibition of insulin secretion by IL-1β, and accounts for the phenomenon of synergism between IL-1β and TNF-α. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0014-5793 1873-3468 |
DOI: | 10.1016/0014-5793(90)80502-A |